Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Sales | 1 | 0 | 1 | 0 | 283 |
| Gross Profit | 1 | N/A | 1 | N/A | 283 |
| Operating Expenses | 2,733 | 3,960 | 3,685 | 2,115 | 1,467 |
| Operating Income | -2,732 | -3,960 | -3,684 | -2,115 | -1,184 |
| Pre-tax Income | -2,732 | -3,960 | -3,684 | -2,115 | -1,184 |
| Net Income Continuous | -2,732 | -3,960 | -3,684 | -2,115 | -1,184 |
| Net Income | $-2,732 | $-3,960 | $-3,684 | $-2,115 | $-1,184 |
| EPS Basic Total Ops | -0.22 | -0.32 | -0.30 | -0.20 | -0.13 |
| EPS Basic Continuous Ops | -0.23 | -0.32 | -0.30 | -0.20 | -0.12 |
| EPS Diluted Total Ops | -0.22 | -0.32 | -0.30 | -0.20 | -0.13 |
| EPS Diluted Continuous Ops | -0.23 | -0.32 | -0.30 | -0.20 | -0.12 |
| EBITDA(a) | $-2,701 | $-3,930 | $-3,656 | $-2,089 | $-1,157 |